Ladenburg Thalmann Financial Services’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-200
Closed -$15K 4979
2015
Q3
$15K Hold
200
﹤0.01% 3309
2015
Q2
$15K Hold
200
﹤0.01% 3448
2015
Q1
$10K Hold
200
﹤0.01% 3676
2014
Q4
$7K Hold
200
﹤0.01% 3621
2014
Q3
$7K Hold
200
﹤0.01% 3298
2014
Q2
$8K Buy
+200
New +$6.98K ﹤0.01% 3218

Ladenburg Thalmann Financial Services's KYTH Position: Q4 2015 in Review

Ladenburg Thalmann Financial Services sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 200 shares — an estimated $15K sold.

Ladenburg Thalmann Financial Services first reported a position in KYTH in Q2 2014 and held it in 6 quarters. The position peaked at $15K in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Ladenburg Thalmann Financial Services reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 200 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $15K.
  • Ladenburg Thalmann Financial Services first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2014 and held it in 6 quarters.
  • Ladenburg Thalmann Financial Services's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $15K in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2015, filed 16 Feb 2016.